He joined a cancer vaccine trial at UCSF. The results could mark a turning point — Live Feedhttps://www.live-feeds.com/feed/he-joined-a-cancer-vaccine-trial-at-ucsf-the-results-could-mark-a-turning-pointContinuously updated, source-cited coverage. Moderna and Merck mRNA Vaccine Reduces Melanoma Recurrencehttps://www.live-feeds.com/feed/he-joined-a-cancer-vaccine-trial-at-ucsf-the-results-could-mark-a-turning-pointhttps://www.live-feeds.com/feed/he-joined-a-cancer-vaccine-trial-at-ucsf-the-results-could-mark-a-turning-point#u47709Tue, 25 Aug 2026 00:11:41 +0000Moderna and Merck report that their joint mRNA vaccine prevents melanoma from returning. The treatment is part of a broader effort to develop vaccines against cancer, with clinical trials conducted at institutions including UCSF. While some reports describe the results as a triumph, others suggest that public enthusiasm for the vaccine is outpacing the actual mathematical data. The treatment aims to revolutionize how doctors manage cancer by preventing relapse after primary treatment.Why it mattersmRNA technology, used in COVID-19 vaccines, is being adapted to target cancer cells. This shift r